Coenzyme Q₁₀ (CoQ₁₀) is a coenzyme and antioxidant involved in multiple bioenergetic and biosynthetic processes, particularly within mitochondria. The biosynthesis of CoQ₁₀ is a tightly regulated process that involves multiple enzymes, including the methyltransferase COQ5. Genetic defects in COQ5 have recently been associated with autosomal recessive COQ5-related primary CoQ₁₀ deficiency. The clinical manifestations of seven individuals previously reported were primarily neurological and ophthalmological. Here, we report two siblings with profound developmental delay and brain imaging consistent with multistage strokes. Clinical exome sequencing revealed compound heterozygous variants in COQ5, including one frameshift deletion and one missense variant. Our functional complementation studies demonstrate that a Saccharomyces cerevisiae COQ5 ortholog harboring the corresponding missense variant fails to fully rescue coq5∆ CoQ₆ production, leading to the accumulation of CoQ biosynthetic intermediates. After the diagnosis, CoQ₁₀ supplementation was started on the proband, leading to subjective clinical improvement. We describe new cases of COQ5-related primary CoQ₁₀ deficiency and expand the phenotypic and molecular spectrum of the disease. We also establish a yeast system to evaluate the effects of the variants in COQ5 and support the use of CoQ₁₀ supplementation for patients with COQ5-related primary CoQ₁₀ deficiency.

• PMID: 41199775
• DOI full text
• PMC full text
• PubMed
• PubTator

Reference Type

Journal Article

Authors

Wongkittichote P, Guerra RM, Wegner DJ, Toy S, Hauer JA, Pagliarini DJ, Granadillo JL

Primary Lit For

Additional Lit For

Review For